Sections
Nephrology
Biography
Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), renal amyloidosis, cardiorenal syndrome, diabetic kidney disease (DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include predictors of CKD progression using CRIC cohort and UK biobank, predictors of mortality using NHANES, a Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease, and the role of intravitreal VEGF inhibitors in causing nephrotoxicity, and renal physiology of decongestion in patients with Acute decompensated heart failure(ADHF). Dr. Verma is a member of the APRC committee for the Framingham Heart Study, the Renal subgroup for clinical endpoints in Amyloidosis for the Amyloidosis research consortium, and the Membership Committee for Kidney in Cardiovascular Medicine for the American Heart Association. He is on the Editorial Board of Therapeutic Advances in Endocrinology and Metabolism, Therapeutic Advances in Chronic Disease, Plos One, and BMC Medicine.
Education
Medicine, MBBS, Stanley Medical School
Publications
Anand S, O'Neill-Dee M, Sanchorawala V, Verma A. Light Chain (AL) Amyloidosis for Nephrologists - Treatment Standard. Nephrol Dial Transplant. 2024 Oct 07. PMID: 39375844.
Published on 9/11/2024Anand SK, Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V, Verma A. Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease. Am J Hematol. 2024 Sep 11. PMID: 39257247.
Published on 8/27/2024Schmidt IM, Surapaneni AL, Zhao R, Upadhyay D, Yeo WJ, Schlosser P, Huynh C, Srivastava A, Palsson R, Kim T, Stillman IE, Barwinska D, Barasch J, Eadon MT, El-Achkar TM, Henderson J, Moledina DG, Rosas SE, Claudel SE, Verma A, Wen Y, Lindenmayer M, Huber TB, Parikh SV, Shapiro JP, Rovin BH, Stanaway IB, Sathe NA, Bhatraju PK, Coresh J, Rhee EP, Grams ME, Waikar SS. Plasma proteomics of acute tubular injury. Nat Commun. 2024 Aug 27; 15(1):7368. PMID: 39191768.
Published on 6/3/2024Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Jun 03. PMID: 38825979.
Published on 5/15/2024Chugh PV, Danford J, Farber A, Ayalon N, Verma A, Helm RH, Monahan KM, Kalish JA. Retrieval of Embolized WATCHMAN® Flex Atrial Appendage Occlusion Device. Vasc Endovascular Surg. 2024 Oct; 58(7):752-756. PMID: 38747057.
Published on 4/2/2024Verma A, Schmidt IM, Claudel S, Palsson R, Waikar SS, Srivastava A. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria : A Cohort Study. Ann Intern Med. 2024 Apr; 177(4):467-475. PMID: 38560911.
Published on 3/14/2024Anand SK, Sanchorawala V, Verma A. Systemic Amyloidosis and Kidney Transplantation: An Update. Semin Nephrol. 2024 Jan; 44(1):151496. PMID: 38490903.
Published on 12/11/2023Claudel SE, Schmidt IM, Gopal DM, Verma A. Elevated cardiac biomarkers in relatively healthy U.S. adults. Eur J Intern Med. 2024 Mar; 121:152-154. PMID: 38087666.
Published on 12/5/2023Claudel SE, Verma A. Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive care. Cell Metab. 2023 Dec 05; 35(12):2104-2106. PMID: 38056429.
Published on 10/10/2023Srivastava A, Amodu A, Liu J, Verma A, Mothi SS, Palsson R, Stillman IE, Kestenbaum BR, Waikar SS. The Associations of Urine Albumin-Protein Ratio With Histopathologic Lesions and Clinicopathologic Diagnoses in Individuals With Kidney Disease. Am J Kidney Dis. 2024 Apr; 83(4):557-560. PMID: 37827424.
Media Mentions
Published on 6/12/2024
Published on 5/21/2024
What is CKM Syndrome? Report Finds Most Americans Meet Criteria For Early Stages
Published on 4/10/2024
Even Normal-Range Albuminuria May Increase Risk of CKD Progression, Kidney Failure
Published on 4/10/2024
Published on 4/4/2024
Patients with CKD and Normoalbuminuria May Have Higher Risk for Disease Progression
Published on 4/2/2024
CKD Progression Risk Up With Increasing Albuminuria in Normal Range
Published on 4/2/2024
CKD Progress Risk Increased Even if Albuminuria Range Normal
Published on 4/1/2024
CKD Progression Risk Up With Increasing Albuminuria in Normal Range
Published on 10/17/2023
What Is CKM Syndrome? American Heart Association Identifies New Medical Condition
Published on 8/10/2022
High Aldosterone Levels Increase Risk for CKD Progression
View full list of 12 media mentions.